Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Nagaraja Rao

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
The Indian Journal of Medical Research|January 26, 2008
Resurrection of DDTP Nagaraja Rao
Journal of Viral Hepatitis|September 8, 2009
Dietary alterations due to perceptions in acute viral hepatitis lead to sub-optimal calorie intake and increased length of hospitalizationE Sathiaraj, M Chutke, S Mahurkar, et al.
Hepatology (Baltimore, Md.)|November 24, 2020
Letter to the Editor: Living Donor Liver Transplantation or Deceased Donor Liver Transplantation in High Model for End-Stage Liver Disease Score-Which Is Better?Anand V Kulkarni, Pramod Kumar, Mithun Sharma, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|December 16, 2021
Endoscopic sleeve gastroplasty - minimally invasive treatment for non-alcoholic fatty liver disease and obesityNitin Jagtap, Rakesh Kalapala, Abhishek Katakwar, et al.
Journal of Clinical and Experimental Hepatology|March 25, 2025
Predictors of Non-response to Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma: A Multicentre Real World Study (HCC-AB Study)Satender P Singh, Karan Kumar, Anand Kulkarni, et al.
Journal of Liver Cancer|May 27, 2024
Downstaging with atezolizumab-bevacizumab: a case seriesAnand V Kulkarni, Parthasarathy Kumaraswamy, Balachandran Menon, et al.
The American Journal of Gastroenterology|April 26, 2019
Drug-Induced Acute-on-Chronic Liver Failure in Asian PatientsHarshad Devarbhavi, Ashok Kumar Choudhury, Manoj Kumar Sharma, et al.
JHEP Reports : Innovation in Hepatology|July 17, 2023
MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitisLuis Antonio Díaz, Eduardo Fuentes-López, Gustavo Ayares, et al.
Hepatology (Baltimore, Md.)|April 12, 2024
An artificial intelligence-generated model predicts 90-day survival in alcohol-associated hepatitis: A global cohort studyWinston Dunn, Yanming Li, Ashwani K Singal, et al.
Journal of Hepatology|June 24, 2021
Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide studyJuan Pablo Arab, Luis Antonio Díaz, Natalia Baeza, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The Indian Journal of Medical Research|January 26, 2008
Resurrection of DDTP Nagaraja Rao
Journal of Viral Hepatitis|September 8, 2009
Dietary alterations due to perceptions in acute viral hepatitis lead to sub-optimal calorie intake and increased length of hospitalizationE Sathiaraj, M Chutke, S Mahurkar, et al.
Hepatology (Baltimore, Md.)|November 24, 2020
Letter to the Editor: Living Donor Liver Transplantation or Deceased Donor Liver Transplantation in High Model for End-Stage Liver Disease Score-Which Is Better?Anand V Kulkarni, Pramod Kumar, Mithun Sharma, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|December 16, 2021
Endoscopic sleeve gastroplasty - minimally invasive treatment for non-alcoholic fatty liver disease and obesityNitin Jagtap, Rakesh Kalapala, Abhishek Katakwar, et al.
Journal of Clinical and Experimental Hepatology|March 25, 2025
Predictors of Non-response to Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma: A Multicentre Real World Study (HCC-AB Study)Satender P Singh, Karan Kumar, Anand Kulkarni, et al.
Journal of Liver Cancer|May 27, 2024
Downstaging with atezolizumab-bevacizumab: a case seriesAnand V Kulkarni, Parthasarathy Kumaraswamy, Balachandran Menon, et al.
The American Journal of Gastroenterology|April 26, 2019
Drug-Induced Acute-on-Chronic Liver Failure in Asian PatientsHarshad Devarbhavi, Ashok Kumar Choudhury, Manoj Kumar Sharma, et al.
JHEP Reports : Innovation in Hepatology|July 17, 2023
MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitisLuis Antonio Díaz, Eduardo Fuentes-López, Gustavo Ayares, et al.
Hepatology (Baltimore, Md.)|April 12, 2024
An artificial intelligence-generated model predicts 90-day survival in alcohol-associated hepatitis: A global cohort studyWinston Dunn, Yanming Li, Ashwani K Singal, et al.
Journal of Hepatology|June 24, 2021
Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide studyJuan Pablo Arab, Luis Antonio Díaz, Natalia Baeza, et al.
Pageof 1